A Brisbane-based biotechnology company behind a needle-free vaccine patch has warned it could take its technology offshore after securing a multimillion-dollar funding boost from European authorities, ...
Morning Overview on MSN
Scientists uncover genetic switch that makes pancreatic cancer chemo-proof
Researchers at Duke-NUS Medical School have identified a molecular switch controlled by the protein GATA6 that determines whether pancreatic cancer cells respond to chemotherapy or become resistant.
Heightened immune response to flagellins in commensal gut microbes predicted future CD in healthy first-degree relatives of patients.
Background Monogenic disorders are a major cause of fetal structural anomalies. Most genetic diagnoses involve de novo, biallelic or X linked variants; however, inherited variants in autosomal ...
Ellis Bio, a developer of next-generation epigenomics technologies, today announced the official commercial launch of its SuperMethyltm Max Bisulfite Conversion Kit, a new and gentle methyl conversion ...
Chung’s group captured the transition period directly by improving the time resolution of a method called single-molecule ...
As shelf-stable microarray patch (MAP) platforms move through development and clinical work, a ‘packaging first’ mentality is ...
Shreyas Sen is the Founder and CTO of Quasistatics, Inc. (dba Ixana), which develops Wi-R, a wireless body-area communication technology. He owns shares in the company. How do headphones, toys, ...
Curling, as is the tradition every four years, becomes a beloved sport for Olympics viewers who fall in love all over again with the sport played on ice with giant stones from Scotland and brooms. But ...
Johnny C. Taylor Jr. tackles your workplace questions each week for USA TODAY. Taylor is president and CEO of SHRM, the world's largest trade association of human resources professionals, and author ...
The Evo2 genomic language model can generate short genome sequences, but scientists say further advances are needed to write ...
Multiplexing Breakthroughs, Automation, and Bioinformatics Convergence Position Protein Microarrays as a Strategic Imperative for Precision Medicine LeadersDelray Beach, FL, Feb. 24, 2026 (GLOBE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results